Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;18(8):2073-2075.
doi: 10.1111/jth.14902.

Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients

Affiliations
Comment

Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients

Francisco Sandro Menezes-Rodrigues et al. J Thromb Haemost. 2020 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Basu‐Ray I, Soos MP. Cardiac manifestations of coronavirus (COVID‐19). StatPearls. 2020. - PubMed
    1. Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099. - PMC - PubMed
    1. Negri EM, Piloto BM, Morinaga LK, et al. Heparin therapy improving hypoxia in COVID‐19 patients ‐ a case series. São Paulo; 2020. 10.1101/2020.04.15.20067017. - DOI - PMC - PubMed
    1. Kochi A.N., Tagliari A.P., Forleo G.B., Fassini G.M., Tondo C. Cardiac and arrhythmic complications in patients with COVID‐19. J Cardiovasc Electrophysiol. 2020;31(5):1003–1008. - PMC - PubMed
    1. Burzynski L.C., Humphry M., Pyrillou K., et al. The coagulation and immune systems are directly linked through the activation of interleukin‐1α by Thrombin. Immunity. 2019;50(4):1033–1042.e6. - PMC - PubMed